Amedisys, Inc. Revenue for the Trailing 12 Months (TTM) ending March 31, 2025: USD 2.37 B

Amedisys, Inc. Revenue is USD 2.37 B for the Trailing 12 Months (TTM) ending March 31, 2025, a 5.34% change year over year. Revenue is the total amount of money generated from the sales of goods or services by a company during a specific period.
  • Amedisys, Inc. Revenue for the Trailing 12 Months (TTM) ending March 31, 2024 was USD 2.25 B, a 0.76% change year over year.
  • Amedisys, Inc. Revenue for the Trailing 12 Months (TTM) ending March 31, 2023 was USD 2.23 B, a 0.54% change year over year.
  • Amedisys, Inc. Revenue for the Trailing 12 Months (TTM) ending March 31, 2022 was USD 2.22 B, a 4.97% change year over year.
  • Amedisys, Inc. Revenue for the Trailing 12 Months (TTM) ending March 31, 2021 was USD 2.12 B.
Key Data
Date Revenue Revenue Gross Profit Operating Income